{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:29:38Z","timestamp":1791322178283,"version":"4.3.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T00:00:00Z","timestamp":1415750400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0112014","type":"journal-article","created":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T19:02:46Z","timestamp":1415818966000},"page":"e112014","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":80,"title":["Inhibitors of the Interferon Response Enhance Virus Replication In Vitro"],"prefix":"10.1371","volume":"9","author":[{"given":"Claire E.","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine S.","family":"Adamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,11,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.83391-0","article-title":"Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures","volume":"89","author":"RE Randall","year":"2008","journal-title":"J Gen Virol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1073\/pnas.070525997","article-title":"Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach","volume":"97","author":"J Talon","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.01920-08","article-title":"Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza","volume":"83","author":"J Steel","year":"2009","journal-title":"J Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1016\/j.vaccine.2013.10.061","article-title":"Phase I\/II trial of a replication-deficient trivalent influenza virus vaccine lacking NS1","volume":"31","author":"C Mossler","year":"2013","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1128\/JVI.02501-07","article-title":"Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals","volume":"82","author":"BH Bird","year":"2008","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"10310","DOI":"10.1128\/JVI.05252-11","article-title":"Creation of a recombinant Rift Valley fever virus with a two-segmented genome","volume":"85","author":"B Brennan","year":"2011","journal-title":"J Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1128\/JVI.73.1.466-473.1999","article-title":"Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein","volume":"73","author":"MN Teng","year":"1999","journal-title":"J Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1128\/JVI.02769-12","article-title":"Respiratory syncytial virus modified by deletions of the NS2 gene and amino acid S1313 of the L polymerase protein is a temperature-sensitive, live-attenuated vaccine candidate that is phenotypically stable at physiological temperature","volume":"87","author":"C Luongo","year":"2013","journal-title":"J Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1535-6108(03)00241-1","article-title":"VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents","volume":"4","author":"DF Stojdl","year":"2003","journal-title":"Cancer Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1517\/14712590903170653","article-title":"Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways","volume":"9","author":"S Naik","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1128\/JVI.77.3.2174-2181.2003","article-title":"Virus replication in engineered human cells that do not respond to interferons","volume":"77","author":"DF Young","year":"2003","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1128\/JVI.2.10.955-961.1968","article-title":"Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero)","volume":"2","author":"J Desmyter","year":"1968","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1128\/MCB.6.6.2279","article-title":"Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis","volume":"6","author":"JD Mosca","year":"1986","journal-title":"Mol Cell Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"11723","DOI":"10.1128\/JVI.01145-06","article-title":"The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor 3 and targets it for proteasomal degradation","volume":"80","author":"L Hilton","year":"2006","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0378-1135(89)90033-3","article-title":"Evaluation of techniques to demonstrate foot-and-mouth disease virus in bovine tongue epithelium: comparison of the sensitivity of cattle, mice, primary cell cultures, cryopreserved cell cultures and established cell lines","volume":"20","author":"C House","year":"1989","journal-title":"Vet Microbiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.virol.2010.08.008","article-title":"Heterocellular induction of interferon by negative-sense RNA viruses","volume":"407","author":"S Chen","year":"2010","journal-title":"Virology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1128\/JVI.03383-12","article-title":"Deep sequencing analysis of defective genomes of parainfluenza virus 5 and their role in interferon induction","volume":"87","author":"MJ Killip","year":"2013","journal-title":"J Virol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1073\/pnas.98.2.664","article-title":"Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis","volume":"98","author":"A Bridgen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"9317","DOI":"10.1128\/JVI.74.19.9317-9321.2000","article-title":"Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees","volume":"74","author":"MN Teng","year":"2000","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/viro.1998.9508","article-title":"Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems","volume":"252","author":"A Garcia-Sastre","year":"1998","journal-title":"Virology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/viro.2002.1738","article-title":"Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling","volume":"303","author":"B He","year":"2002","journal-title":"Virology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1743-422X-3-63","article-title":"New low-viscosity overlay medium for viral plaque assays","volume":"3","author":"M Matrosovich","year":"2006","journal-title":"Virol J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1074\/jbc.M109.000414","article-title":"Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation","volume":"284","author":"K Clark","year":"2009","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/BJ20101701","article-title":"Novel cross-talk within the IKK family controls innate immunity","volume":"434","author":"K Clark","year":"2011","journal-title":"Biochem J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1124\/jpet.104.074484","article-title":"Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB Kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell Proliferation","volume":"312","author":"PL Podolin","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/leu.2009.50","article-title":"CYT387, a selective JAK1\/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients","volume":"23","author":"A Pardanani","year":"2009","journal-title":"Leukemia"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccr.2009.10.015","article-title":"The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors","volume":"16","author":"M Hedvat","year":"2009","journal-title":"Cancer Cell"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2009-04-214957","article-title":"Preclinical characterization of the selective JAK1\/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms","volume":"115","author":"A Quintas-Cardama","year":"2010","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.1087061","article-title":"Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor","volume":"302","author":"PS Changelian","year":"2003","journal-title":"Science"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/227168a0","article-title":"Characteristics of a human diploid cell designated MRC-5","volume":"227","author":"JP Jacobs","year":"1970","journal-title":"Nature"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"10710","DOI":"10.1128\/JVI.00986-09","article-title":"Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans","volume":"83","author":"S Kwilas","year":"2009","journal-title":"J Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4049\/jimmunol.54.3.283","article-title":"Attenuation of virulence with retention of antigenicity of mumps virus after passage in the embryonated egg","volume":"54","author":"JF Enders","year":"1946","journal-title":"J Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jama.1968.03150030043009","article-title":"Development and evaluation of the Moraten measles virus vaccine","volume":"206","author":"MR Hilleman","year":"1968","journal-title":"Jama"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"S533","DOI":"10.1093\/infdis\/jir097","article-title":"Genetic characterization of measles vaccine strains","volume":"204","author":"B Bankamp","year":"2011","journal-title":"J Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1099\/vir.0.013722-0","article-title":"Mumps virus Enders strain is sensitive to interferon (IFN) despite encoding a functional IFN antagonist","volume":"90","author":"DF Young","year":"2009","journal-title":"J Gen Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/cgt.2013.55","article-title":"Overcoming cancer cell resistance to VSV oncolysis with JAK1\/2 inhibitors","volume":"20","author":"D Escobar-Zarate","year":"2013","journal-title":"Cancer Gene Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1517\/14656566.2012.732998","article-title":"Ruxolitinib, an oral JAK1 and JAK2 inhibitor, in myelofibrosis","volume":"13","author":"K Vaddi","year":"2012","journal-title":"Expert Opin Pharmacother"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0112014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T02:43:03Z","timestamp":1689648183000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0112014"}},"subtitle":[],"editor":[{"given":"Stephania Ann","family":"Cormier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,12]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0112014","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,12]]}}}